On August 7, 2023, CELANESE CORPORATION ($NYSE:CE) reported their earnings results for the second quarter of FY2023, which ended on June 30, 2023. Total revenue amounted to USD 2795.0 million, signifying a 12.4% increase from the same period in the previous year. However, net income was USD 220.0 million, showing a decrease of 49.3% compared to the same quarter of the prior year.
The company’s stock opened at $124.6 and closed at $124.7, up by 0.6% from the previous closing price of $124.0. The company continues to focus on cost reduction initiatives, portfolio optimization and innovation-led growth. With a strong position in the market and resilient business model, the company is well-positioned for future success. Live Quote…
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Celanese Corporation. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Celanese Corporation. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Celanese Corporation. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Celanese Corporation are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
Analysis – Celanese Corporation Intrinsic Value Calculation
At GoodWhale, we have conducted an in-depth analysis of the financials of CELANESE CORPORATION. After careful consideration of all factors, we have determined that the fair value of CELANESE CORPORATION share is roughly $171.0, using our proprietary Valuation Line. Currently, CELANESE CORPORATION stock is traded at $124.7, significantly lower than our calculated fair value. This presents a great investment opportunity as the stock is currently undervalued by 27.1%. More…
Risk Rating Analysis
Star Chart Analysis
Celanese’s product portfolio includes acetyl intermediates, plastics, films, and synthetic fibers. The company operates in two segments: Advanced Engineered Materials and Industrial Specialties. Celanese’s competitors include Dow Inc, DuPont de Nemours Inc, and Showa Denko KK.
Dow Inc is a publicly traded company with a market capitalization of $35.24 billion as of 2022. The company’s return on equity is 26.96%. Dow Inc is a diversified chemical company that produces and sells chemicals, plastics, and agricultural products. The company operates in more than 80 countries and employs approximately 36,000 people.
– DuPont de Nemours Inc ($NYSE:DD)
DuPont de Nemours Inc is a large chemical company with a market cap of 34.47B as of 2022. The company has a ROE of 6.8%. DuPont is a science company that delivers science-based solutions to make people’s lives better, healthier and safer.
– Showa Denko KK ($TSE:4004)
Show Denko KK is a Japanese company that manufactures and sells chemicals and materials. The company has a market capitalization of 406.88 billion as of 2022 and a return on equity of 7.29%. Showa Denko is a diversified company with businesses ranging from petrochemicals to electronics. The company is one of the largest producers of aluminum oxide in the world and also produces and sells a variety of other chemicals and materials.
Investors should take note of CELANESE CORPORATION’s second quarter results ending on June 30 2023, which marked an increase of 12.4% in total revenue to USD 2795.0 million from the same period a year ago. However, net income decreased by 49.3% to USD 220.0 million, resulting in a decrease in shareholders’ profitability. Although revenue has seen impressive growth, investors should be aware that the company’s profitability is down. Further research into the company’s future outlook and current performance may be necessary in order to determine whether or not investing in CELANESE CORPORATION is a wise decision.